vs

Side-by-side financial comparison of Invivyd, Inc. (IVVD) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.

Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $11.1M, roughly 1.6× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -64.3%, a 75.3% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs -5.6%).

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

IVVD vs MDV — Head-to-Head

Bigger by revenue
IVVD
IVVD
1.6× larger
IVVD
$17.2M
$11.1M
MDV
Growing faster (revenue YoY)
IVVD
IVVD
+30.1% gap
IVVD
24.5%
-5.6%
MDV
Higher net margin
MDV
MDV
75.3% more per $
MDV
11.0%
-64.3%
IVVD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVVD
IVVD
MDV
MDV
Revenue
$17.2M
$11.1M
Net Profit
$-11.1M
$1.2M
Gross Margin
Operating Margin
-73.0%
45.8%
Net Margin
-64.3%
11.0%
Revenue YoY
24.5%
-5.6%
Net Profit YoY
40.0%
-22.0%
EPS (diluted)
$0.02
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVVD
IVVD
MDV
MDV
Q4 25
$17.2M
$11.1M
Q3 25
$13.1M
$11.7M
Q2 25
$11.8M
$11.8M
Q1 25
$11.3M
$11.8M
Q4 24
$13.8M
$11.7M
Q3 24
$9.3M
$11.7M
Q2 24
$2.3M
$11.4M
Q1 24
$0
$12.0M
Net Profit
IVVD
IVVD
MDV
MDV
Q4 25
$-11.1M
$1.2M
Q3 25
$-10.5M
$1.0M
Q2 25
$-14.7M
$-2.0M
Q1 25
$-16.3M
$829.0K
Q4 24
$-18.4M
$1.6M
Q3 24
$-60.7M
$-587.0K
Q2 24
$-47.2M
$1.3M
Q1 24
$-43.5M
$3.7M
Operating Margin
IVVD
IVVD
MDV
MDV
Q4 25
-73.0%
45.8%
Q3 25
-84.0%
41.4%
Q2 25
-127.8%
9.8%
Q1 25
-149.7%
40.2%
Q4 24
-139.1%
45.4%
Q3 24
-670.0%
42.0%
Q2 24
-2175.2%
44.6%
Q1 24
55.6%
Net Margin
IVVD
IVVD
MDV
MDV
Q4 25
-64.3%
11.0%
Q3 25
-79.7%
9.0%
Q2 25
-124.4%
-17.1%
Q1 25
-144.1%
7.0%
Q4 24
-133.5%
13.3%
Q3 24
-653.1%
-5.0%
Q2 24
-2086.9%
11.6%
Q1 24
31.1%
EPS (diluted)
IVVD
IVVD
MDV
MDV
Q4 25
$0.02
$0.02
Q3 25
$-0.06
$0.00
Q2 25
$-0.12
$-0.32
Q1 25
$-0.14
$-0.01
Q4 24
$-0.14
$0.07
Q3 24
$-0.51
$-0.18
Q2 24
$-0.40
$0.03
Q1 24
$-0.38
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVVD
IVVD
MDV
MDV
Cash + ST InvestmentsLiquidity on hand
$226.7M
$14.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$241.5M
$162.7M
Total Assets
$276.9M
$476.5M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVVD
IVVD
MDV
MDV
Q4 25
$226.7M
$14.4M
Q3 25
$85.0M
$8.3M
Q2 25
$34.9M
$5.8M
Q1 25
$48.1M
$6.2M
Q4 24
$69.3M
$11.5M
Q3 24
$106.9M
$6.8M
Q2 24
$147.9M
$18.9M
Q1 24
$189.4M
$18.4M
Total Debt
IVVD
IVVD
MDV
MDV
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$279.8M
Q3 24
$279.7M
Q2 24
$279.7M
Q1 24
$279.6M
Stockholders' Equity
IVVD
IVVD
MDV
MDV
Q4 25
$241.5M
$162.7M
Q3 25
$93.1M
$164.8M
Q2 25
$42.8M
$165.6M
Q1 25
$54.1M
$171.1M
Q4 24
$67.5M
$190.1M
Q3 24
$83.2M
$186.3M
Q2 24
$140.6M
$187.0M
Q1 24
$178.5M
$188.0M
Total Assets
IVVD
IVVD
MDV
MDV
Q4 25
$276.9M
$476.5M
Q3 25
$139.2M
$499.6M
Q2 25
$89.1M
$498.9M
Q1 25
$103.7M
$506.8M
Q4 24
$129.5M
$507.8M
Q3 24
$161.9M
$507.4M
Q2 24
$177.3M
$519.5M
Q1 24
$215.5M
$522.5M
Debt / Equity
IVVD
IVVD
MDV
MDV
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
1.47×
Q3 24
1.50×
Q2 24
1.50×
Q1 24
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVVD
IVVD
MDV
MDV
Operating Cash FlowLast quarter
$-15.5M
$15.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVVD
IVVD
MDV
MDV
Q4 25
$-15.5M
$15.0M
Q3 25
$-8.3M
$4.1M
Q2 25
$-13.3M
$3.9M
Q1 25
$-21.1M
$3.0M
Q4 24
$-37.6M
$18.2M
Q3 24
$-41.1M
$5.1M
Q2 24
$-41.6M
$4.7M
Q1 24
$-50.2M
$3.0M
Free Cash Flow
IVVD
IVVD
MDV
MDV
Q4 25
Q3 25
Q2 25
$-13.3M
Q1 25
$-21.3M
Q4 24
$-37.6M
Q3 24
$-41.1M
Q2 24
Q1 24
$-50.4M
FCF Margin
IVVD
IVVD
MDV
MDV
Q4 25
Q3 25
Q2 25
-112.9%
Q1 25
-188.2%
Q4 24
-272.2%
Q3 24
-441.6%
Q2 24
Q1 24
Capex Intensity
IVVD
IVVD
MDV
MDV
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
1.3%
Q4 24
0.0%
Q3 24
0.1%
Q2 24
0.0%
Q1 24
Cash Conversion
IVVD
IVVD
MDV
MDV
Q4 25
12.34×
Q3 25
3.95×
Q2 25
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons